Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Jargon redux.

Bone marrow transplantation·2026

Same author

Site-specific methylation of SRSF2<sup>P95H</sup> by SETD2 inhibits MDSC-mediated proinflammatory niche formation in mouse models of myelodysplastic syndrome.

Science translational medicine·2026

Same author

Chronic myeloid leukaemia: have basophils gone the way of the Dodo bird?

Leukemia·2026

Same author

Sex-Related Differences in Clinical Features, Inflammatory Cytokines, Mutation Topography, Outcomes, and Prognostic Models in Patients With Myeloproliferative Neoplasms.

American journal of hematology·2026

Same author

Physician-complementing artificial intelligence in haematology: ushering in a new era.

Leukemia·2026

Same author

Things that drive Editors crazy: jargon, unnecessary abbreviations, abusing decimals and a few more.

Leukemia·2025

Search research articles

Related Experiment Video

Updated: Oct 6, 2025

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice

Published on: January 6, 2023

Progress in Transplants for Acute Lymphoblastic Leukemia.

Robert Peter Gale¹

¹Centre for Hematology Research, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research

|January 14, 2022

Summary

Hematopoietic cell transplants can treat high-risk acute lymphoblastic leukemia (ALL). While leukemia relapse post-transplant is a challenge, new therapies are improving outcomes and survival rates for recurrent ALL.

More Related Videos

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

Related Experiment Videos

Last Updated: Oct 6, 2025

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice

Published on: January 6, 2023

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

Area of Science:

Hematology
Oncology
Transplant Immunology

Background:

Hematopoietic cell transplantation is a key treatment for adults with high-risk acute lymphoblastic leukemia (ALL), particularly those with BCR::ABL1.
The advent of safe and effective tyrosine kinase inhibitors (TKIs) may alter the landscape of ALL treatment strategies.
Leukemia relapse remains the primary obstacle to long-term success following hematopoietic cell transplantation.

Discussion:

The article reviews various strategies to address post-transplant leukemia recurrence.
Emerging therapies for relapsed leukemia after transplantation are showing increasing success.
Multiple factors contribute to the observed substantial improvements in survival rates.

Key Insights:

High-risk ALL patients benefit from hematopoietic cell transplants.
Tyrosine kinase inhibitors offer a promising alternative or adjunct therapy.
Effective management of post-transplant relapse is crucial for improving patient survival.

Outlook:

Continued research into novel therapeutic approaches for relapsed leukemia post-transplant is essential.
Integration of TKIs with transplantation may offer synergistic benefits.
Improved treatment protocols are leading to better survival outcomes for ALL patients.